Abstract-The effect of zotepine (2-chloro-1 1 -(2-dimethyl-aminoethoxy) dibenzo [b, f] thiepin), a new neuroleptic, and other neuroleptics, minor tranquilizers, antidepressants, anticholinergic drugs, antihistamine drugs, antiparkinsonian drugs, a-, 3-adrenergic blocking agents, hypnotics and central muscle relaxants on apomorphine (APM) and methamphetamine (MAP)-induced rotational behaviour was investigated in rats with unilateral lesions of the substantia nigra. Only the neuroleptics dose-dependently depressed both rotational behaviours. The minor tranquilizers also depressed both behaviours, but their effect was non-specific. The neuroleptics could be divided into two groups according to their relative effect on the APM and MAP-induced rotational behaviour. The high-ratio group (fluphenazine, haloperidol, perphenazine, pimozide and zotepine) depressed the MAP-induced rotational behaviour more strongly than the APM-induced one, whereas the depressive effect of the low-ratio group (chlorpromazine, levomepromazine, thioridazine and clozapine) was the reverse. Zotepine, while belong ing to the high-ratio group, was markedly lower in ratio than the other neuroleptics in this group. The correlation between the different effect of the two groups of neuroleptics and their clinical effect is discussed.
Since
Ungerstedt (1, 2) reported dopaminergic agonist-induced rotational be haviour in rats with unilateral lesions of the substantia nigra, rotational behaviour has been used as a model for detecting the mode of action and potency of dopaminergic agonists as well as dopaminergic antagonists (3) (4) (5) (6) (7) (8) In contrast, perphenazine, flu phenazine, haloperidol and pimozide were 10 or more times stronger against MAP induced rotational behaviour than APM induced rotational behaviour, as shown by the A/M ratio in Table 1 . According to the A/M ratio, neuroleptics can be divided into two groups, that is, one has a high A/M ratio of over 1, and the other has a low A/M ratio of less than 1. The former group consists Propranolol also had no effect on rotational behaviour, whereas phentolamine and tolazoline in hibited the rotational behaviour only at very high doses. The antihistamine drugs had no effect, and the hypnotics and the central muscle relaxants were also ineffective, since the ED50 values of phenobarbital chlor mezanone and -butyrolactone were near to the doses which caused loss of the righting reflex in rats. Thus none of the miscellaneous drugs tested had significant inhibitory effect on rotational behaviour at a pharmacologically useful range. Effect of haloperidol and diazepam on dose-response curves of APM and MAP induced rotational behaviour: As shown in both Figs. 3 and 4 , haloperidol, in doses of 0.064 mg/kg and over and 0.032 mg/kg and over, produced a parallel shift of the dose response curves of the APM and MAP Table 2 . Effect (ED50) of various drugs on apomorphine and methamphetamine-induced rotational behaviour.
All drugs were given i.p. 1 hr before apomorphine and methamphetamine. '-4: At a dose of 64 mg/kg, three of ten, eight of ten, five of ten, and three of ten animals died, respectively.
Dose of apomorphine (mg/kcg, i.p.) 
Discussion
Neuroleptics including zotepine dose dependently depressed both APM and MAP induced rotational behaviour in rats with unilateral lesions of the substantia nigra. The rank of order of depressive effect seems to be near to that obtained by screening of the catalepsy inducing effect or inhibition of dopamine-agonists-induced stereotyped be haviours (15). On the other hand, minor tranquilizers and miscellaneous drugs were non-specific or had no effect, respectively. In the present study, neuroleptics could be divided into two groups by the A/M ratio. Zotepine, while belonging to the high ratio group, is markedly lower in A/M ratio than the other neuroleptics in this group, that is, zotepine stands just mid-way between the high and low groups. Zotepine is reported to have a strong and broad effect in clinical use and is characterized by almost the same anti-hallucinatory effect as haloperidol, fewer extrapyramidal symptoms than known neu roleptics, and no overdepression of con sciousness as in the case of chlorpromazine (28-30). These characteristics of zotepine in clinical use might be reflected partially by the A/M ratio in the present study, though zotepine has other effects, a potent anti serotonergic as well as an anti-dopaminergic effect in animal models (7, 31).
Bobon et al. (32) clinically classified the neuroleptic effect of neuroleptics into mainly ataraxic, anti-delusional, anti-manic and anti autistic effects and scored their potencies according to the strength of each effect. Chlorpromazine, thioridazine and levome promazine are reported to be very ataraxic, the ataraxic effect of these drugs being stronger than the other three neuroleptic effects.
On the other hand, haloperidol, fluphenazine and pimozide are much stronger in anti-delusional and anti-manic effects than the other neuroleptic effects, and the potency of the anti-delusional and anti manic effects is parallel. Clozapine is also reported to be almost the same as levome promazine in the ataraxic effect (33) . These findings seem to be correlated with the rank of order of the A/M ratio; neuroleptics of the high-ratio group are anti-delusional and anti-manic, and neuroleptics of the low ratio group are ataraxic. In light of these speculations and the A/M ratio of zotepine in the present study, it might be suggested that zotepine occupies its own special position in clinical use. It is interesting that the profile of new drugs can be suggested on the basis of the results in animal models since these neuroleptics will be used properly according to the symptoms of patients; however, further investigation is necessary to clarify the effect of neuroleptics and predict their clinical effects. We are expecting the clinical effect of zotepine in the future. 
